Efficacy of Intravenous Ferric Carboxymaltose in the Improvement of Anemia in Patients With Postoperative Knee Prosthesis [Eficacia del hierro intravenoso carboximaltosa para la mejoria de la anemia postoperatoria en pacientes de protesis de rodilla]

Trial Profile

Efficacy of Intravenous Ferric Carboxymaltose in the Improvement of Anemia in Patients With Postoperative Knee Prosthesis [Eficacia del hierro intravenoso carboximaltosa para la mejoria de la anemia postoperatoria en pacientes de protesis de rodilla]

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 May 2014

At a glance

  • Drugs Ferric carboxymaltose (Primary) ; Ferrous glycine sulfate
  • Indications Anaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 May 2014 New trial record
    • 29 Apr 2014 Primary endpoint 'Haemoglobin-level' has not been met.
    • 29 Apr 2014 Primary endpoint 'Disease-control-rate' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top